Be Familiar With Oral Semaglutide for Heart Protection

March 2026

Oral semaglutide (Rybelsus) will now be used to lower cardiovascular risk in some adults with high-risk type 2 diabetes.

Injectable semaglutide (Ozempic) and other injectable GLP-1 agonists (dulaglutide, etc) are already used for lowering cardiovascular risk in some patients with type 2 diabetes.

Now evidence shows that oral semaglutide 14 mg/day is another option for lowering cardiovascular risk in these patients.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Diabetes Be Familiar With Oral Semaglutide for Heart Protection
Women's Health Put Meds for Uterine Fibroids in Perspective
Fibromyalgia Know How Meds for Fibromyalgia Stack Up
Med Safety Stay Alert for Confusing Abbreviations
Hypertension Avoid Common Blood Pressure Measurement Errors
Endocrinology Minimize Mishaps With Aldosterone Antagonists
Transplantation Help Prevent Med Errors in Transplant Patients
NatMed Spotlight Be Ready With Answers About Biotin

Be Familiar With Oral Semaglutide for Heart Protection

Practical advice for a better career, with unlimited access to CE

Table of Contents